Henry-Joyce Cancer Center — Nashville, Tennessee

Henry-Joyce Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Henry-Joyce Cancer Center has participated in 9 clinical trials with 2 currently active.

Therapeutic areas: Small Cell Lung Carcinoma, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), High-risk Large B-cell Lymphoma (LBCL).

Sponsors: Bristol-Myers Squibb, Kite, A Gilead Company, Pfizer.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry-Joyce Cancer Center?

Henry-Joyce Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry-Joyce Cancer Center conducted?

Henry-Joyce Cancer Center has 9 clinical trials on record, with 2 currently active. Their work covers Small Cell Lung Carcinoma, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), High-risk Large B-cell Lymphoma (LBCL).

Is Henry-Joyce Cancer Center accredited by Crixeo Health?

Yes — Henry-Joyce Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Henry-Joyce Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.